Archive · 24 Jul 2025
Pharma Industry News: Financials, Partnerships and Acquisitions
Several pharmaceutical companies made significant announcements on July 24, 2025.
Dr. Reddy's saw a small profit increase despite challenges in North America.
Apollo Hospitals and Siemens Healthineers are teaming up for liver disease research.
Biocon Biologics has a new head of communications.
Glenmark Pharmaceuticals faced a warning from the US FDA due to manufacturing issues.
Finally, Natco Pharma made an offer to buy a substantial part of a South African drug company.
Dr. Reddy's Laboratories' Q1 profit increased marginally, revenue rose by 11%.
Apollo Hospitals and Siemens Healthineers are collaborating on liver healthcare research.
Biocon Biologics appointed Deepali Naair as Global Head of Brand & Corporate Communications.
Glenmark Pharmaceuticals received a USFDA warning for manufacturing lapses at its Pithampur plant.
Natco Pharma offered to acquire a 36% stake in Adcock Ingram Holdings for up to Rs 2,100 crore.
- Who
- Dr. Reddy's Laboratories, Apollo Hospitals, Siemens Healthineers, Biocon Biologics, Glenmark Pharmaceuticals, and Natco Pharma.
- What
- Several pharmaceutical companies announced updates, including financial results, partnerships, and acquisitions.
- When
- July 24, 2025.
- Where
- Hyderabad, Pithampur (India), South Africa and North America.
- Why
- The announcements varied, including financial performance, research initiatives, management changes, regulatory issues and acquisition offers.
- Dr. Reddy's Q1 Profit
- Marginally Increased
- Dr. Reddy's Q1 Revenue Increase
- 11%
- Glenmark Plant Location
- Pithampur, Madhya Pradesh
- Natco Pharma Offer
- To acquire a 36% stake in Adcock Ingram Holdings
- Natco Pharma Offer Value
- Up to Rs 2,100 crore